Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | BACE1 | P56817 | 3/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.65 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.65 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.65 |
| ▸ | KCNA3 | P22001 | 3/20 | 0.62 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | ACHE | P22303 | 1/20 | 0.60 |
| ▸ | PDE4A | P27815 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9184365 | 0.83 | MAOA (0.76) | MAOACYP3A4ALDH1A1BACE1GAA | |
| SCHEMBL10491029 | 0.82 | MAOA (0.78) | MAOACYP3A4ALDH1A1BACE1GAA | |
| SCHEMBL18788617 | 0.82 | MAOA (0.78) | MAOACYP3A4ALDH1A1BACE1GAA | |
| SCHEMBL31546585 | 0.81 | MAOA (0.77) | MAOACYP3A4ALDH1A1BACE1GAA | |
| SCHEMBL14677742 | 0.81 | MAOA (0.73) | MAOACYP3A4ALDH1A1BACE1GAA | |
| SCHEMBL13985912 | 0.81 | MAOA (0.68) | MAOACYP3A4ALDH1A1BACE1GAA | |
| SCHEMBL31232768 | 0.81 | CA9 (0.69) | MAOACYP3A4ALDH1A1BACE1GAA | |
| SCHEMBL2468855 | 0.81 | CA9 (0.69) | MAOACYP3A4ALDH1A1BACE1GAA | |
| SCHEMBL17373028 | 0.81 | MAOA (1.00) | MAOACYP3A4ALDH1A1BACE1GAA | |
| SCHEMBL8806449 | 0.80 | CYP3A4 (0.71) | MAOACYP3A4ALDH1A1BACE1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220106268-A9 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | THE WILLIAM M. YARBROUGH FOUNDATION | 2022-04-07 | — | — | US | disclosed |
| US-11279674-B2 | Isothiocyanate functional surfactant and associated method of use | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2022-03-22 | — | — | US | disclosed |
| US-20210355081-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | SILVER MICHAEL E (US) | 2021-11-18 | — | — | US | disclosed |
| US-10647668-B2 | Isothiocyanate functional surfactant and associated method of use | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2020-05-12 | — | — | US | disclosed |
| US-20190284133-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | THE WILLIAM M. YARBROUGH FOUNDATION | 2019-09-19 | — | — | US | disclosed |
| US-10308600-B2 | Isothiocyanate functional surfactant and associated method of use | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2019-06-04 | — | — | US | disclosed |
| US-20180290972-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | THE WILLIAM M YARBROUGH FOUNDATION | 2018-10-11 | — | — | US | disclosed |
| US-9951004-B2 | Isothiocyanate functional surfactant and associated method of use | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2018-04-24 | — | — | US | disclosed |
| US-9951005-B2 | Isothiocyanate functional surfactant formulation and associated method of use | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2018-04-24 | — | — | US | disclosed |
| US-9951003-B2 | Isothiocyanate functional compound and associated method of use | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2018-04-24 | — | — | US | disclosed |
| US-9771322-B2 | Isothiocyanate functional surfactant and associated method of use | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2017-09-26 | — | — | US | disclosed |
| US-20170037000-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | THE WILLIAM M YARBROUGH FOUNDATION | 2017-02-09 | — | — | US | disclosed |
| US-20170037001-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT FORMULATION AND ASSOCIATED METHOD OF USE | THE WILLIAM M YARBROUGH FOUNDATION | 2017-02-09 | — | — | US | disclosed |
| US-20160030379-A1 | Method for Treating Phytophotodermatitis | THE WILLIAM M YARBROUGH FOUNDATION | 2016-02-04 | — | — | US | disclosed |
| US-20160030381-A1 | Method for Treating Phytophotodermatitis | THE WILLIAM M YARBROUGH FOUNDATION | 2016-02-04 | — | — | US | disclosed |
| US-20160030380-A1 | Method for Treating Phytophotodermatitis | THE WILLIAM M YARBROUGH FOUNDATION | 2016-02-04 | — | — | US | disclosed |
| US-20150126600-A1 | Method for Treating Phytophotodermatitis | THE WILLIAM M YARBROUGH FOUNDATION | 2015-05-07 | — | — | US | disclosed |
| US-8933119-B2 | Method for treating phytophotodermatitis | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2015-01-13 | — | — | US | disclosed |
| WO-2013003601-A1 | METHOD FOR TREATING PHYTOPHOTODERMATITIS | THE WILLIAM M. YARBROUGH FOUNDATION (US) | 2013-01-03 | — | — | WO | disclosed |
| US-20120184621-A1 | METHOD FOR TREATING PHYTOPHOTODERMATITIS | WILLIAM M. YARBROUGH FOUNDATION, THE | 2012-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210355081-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | STOM, TST, SGMS1 | MAOA 4709/4885CYP3A4 3874/4885ALDH1A1 3753/4885 |
| US-20120184621-A1 | METHOD FOR TREATING PHYTOPHOTODERMATITIS | STOM, TST, ABCB4 | MAOA 4467/4885CYP3A4 3387/4885ALDH1A1 3440/4885 |
| US-20180290972-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | STOM, TST, SGMS1 | MAOA 4709/4885CYP3A4 3874/4885ALDH1A1 3753/4885 |
| US-20170037000-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | TST, CFTR, SGMS1 | MAOA 4552/4885CYP3A4 3112/4885ALDH1A1 3220/4885 |
| US-10308600-B2 | Isothiocyanate functional surfactant and associated method of use | STOM, TST, SGMS1 | MAOA 4709/4885CYP3A4 3874/4885ALDH1A1 3753/4885 |
| US-11279674-B2 | Isothiocyanate functional surfactant and associated method of use | STOM, TST, SGMS1 | MAOA 4709/4885CYP3A4 3874/4885ALDH1A1 3753/4885 |
| US-20160030379-A1 | Method for Treating Phytophotodermatitis | STOM, TST, ABCB4 | MAOA 4467/4885CYP3A4 3387/4885ALDH1A1 3440/4885 |
| US-20170037001-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT FORMULATION AND ASSOCIATED METHOD OF USE | SGMS1, TST, SGMS2 | MAOA 4405/4885CYP3A4 3419/4885ALDH1A1 3035/4885 |
| US-20160030380-A1 | Method for Treating Phytophotodermatitis | STOM, TST, ABCB4 | MAOA 4467/4885CYP3A4 3387/4885ALDH1A1 3440/4885 |
| US-20150126600-A1 | Method for Treating Phytophotodermatitis | STOM, TST, ABCB4 | MAOA 4467/4885CYP3A4 3387/4885ALDH1A1 3440/4885 |
| US-10647668-B2 | Isothiocyanate functional surfactant and associated method of use | STOM, TST, SGMS1 | MAOA 4709/4885CYP3A4 3874/4885ALDH1A1 3753/4885 |
| US-20160030381-A1 | Method for Treating Phytophotodermatitis | STOM, TST, ABCB4 | MAOA 4467/4885CYP3A4 3387/4885ALDH1A1 3440/4885 |
| US-20220106268-A9 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | STOM, TST, SGMS1 | MAOA 4709/4885CYP3A4 3874/4885ALDH1A1 3753/4885 |
| US-20190284133-A1 | ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE | STOM, TST, SGMS1 | MAOA 4709/4885CYP3A4 3874/4885ALDH1A1 3753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.